At this year’s ACHEMA, GEA Niro will be available to discuss how GEA Niro’s range of spray drying systems can be applied for production of pharmaceuticals.
The application of spray drying technology offers the pharmaceutical industry a break-through within solid dosage formulations. By providing an unprecedented particle control and allowing previously unattainable delivery methods and molecular characteristics, it opens up new opportunities for new formulations.
Spray drying offers several advantages including increased bioavailability, modified release, aseptic production, particles for inhalation, and improved compressibility.
Niro has developed a series of spray dryers dedicated to manufacturing in the pharmaceutical industry. The range of sizes begins with the R&D lab dryer, SDMICRO™ designed for only 30 kg/h drying gas and continues up to industrial size production GMP dryers with a drying gas capacity of more than 10,000 kg/h.
The philosophy behind the design is that a combination of standardised modules are used to meet the requirement for a specific duty. Therefore, dryers of equal capacity may be completely different with respect to design, configuration and physical size. This allows Niro to focus specifically on the needs of the customer and the demands of the process without physical limitations to the design of the equipment. The dryers are designed to use hot air, or, when drying non-aqueous compounds, nitrogen as the drying gas. They can be used for the drying of a wide range of compounds that are based on acetone, methylene chloride, ethanol, and other organic solvents.
As with all Niro plant equipment, each system component meets the strictest requirements and regulatory standards.
Meet us at ACHEMA, Hall 4.0 stand No. D13-G22
All business enquiries to:
Per Houmann Nielsen
GEA Niro
GEA Process Engineering A/S
Chemical Division - Pharma Spray Drying
Tel: +45 3954 5385
Email:
per.houmann@geagroup.comWeb:
www.niro.com